The University of Texas Health Science Center at Tyler

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center at Tyler sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,751 sponsors by registered trial count).

7 total trials none currently recruiting 7 completed later-stage tilt upper quartile by trial count

The University of Texas Health Science Center at Tyler: 7 sponsored US clinical trials, none currently recruiting.

The University of Texas Health Science Center at Tyler sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 5 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Mycobacterium Avium Complex Lung Disease, with 1 trials.

Upper-quartile sponsor footprint

The University of Texas Health Science Center at Tyler sits in the upper quartile of the sponsor corpus (#1,806 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

COMPLETED NA

Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD

NCT01108991
COMPLETED Phase 2

Tigecycline for Treatment of Rapidly Growing Mycobacteria

NCT00600600
COMPLETED Phase 4

Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease

NCT00598897
COMPLETED Phase 4

Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease

NCT00598962
COMPLETED Phase 4

Azithromycin in the Treatment of M. Avium Complex Lung Disease

NCT00599079
COMPLETED Phase 4

Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)

NCT00600769
COMPLETED Phase 3

Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex

NCT03164291

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1
Phase 4 4

Therapeutic Areas

Mycobacterium Avium Complex Lung Disease 1
Mycobacterium Avium Complex 1
Nontuberculous Mycobacteria 1

How the The University of Texas Health Science Center at Tyler archive is shaped

7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).

Phase mix: 5 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Mycobacterium Avium Complex Lung Disease (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Nationwide sponsors with similar pipelines

Cross-sponsor peers matched on registered trial volume and open-enrollment share, not the same therapeutic-area sidebar.

Similar trial volume (± open share)

Similar open-enrollment share (± trial volume)

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.